10.25384/SAGE.6474014.v1 Steve Deitelzweig Steve Deitelzweig Xuemei Luo Xuemei Luo Kiran Gupta Kiran Gupta Jeffrey Trocio Jeffrey Trocio Jack Mardekian Jack Mardekian Tammy Curtice Tammy Curtice Patrick Hlavacek Patrick Hlavacek Melissa Lingohr-Smith Melissa Lingohr-Smith Brandy Menges Brandy Menges Jay Lin Jay Lin Supplemental Material, Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table - All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants SAGE Journals 2018 elderly nonvalvular atrial fibrillation oral anticoagulants apixaban rivaroxaban dabigatran warfarin stroke systemic embolism major bleeding health-care costs 2018-01-24 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table_-_All-Cause_Stroke_Systemic_Embolism_and_Major_Bleeding-Related_Health-Care_Costs_Among_Elderly_Patients_With_Nonvalvular_Atrial_Fibrillation_Treated_With_Oral_Anticoagulants/6474014 <p>Supplemental Material, Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table for All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants by Steve Deitelzweig, Xuemei Luo, Kiran Gupta, Jeffrey Trocio, Jack Mardekian, Tammy Curtice, Patrick Hlavacek, Melissa Lingohr-Smith, Brandy Menges, and Jay Lin in Clinical and Applied Thrombosis/Hemostasis</p>